Skip to content

Clinical trials

Observational Myeloproliferative Disorders trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Status: Unknown status Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20161
20192
20203
20211
20221
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Brest4
Assistance Publique - Hôpitaux de Paris2
Assiut University2
Shanghai Zhongshan Hospital2
Sohag University2
Carmel Medical Center1
Centre Hospitalier Universitaire de Nīmes1
National Taiwan University Hospital1
Royal Free Hospital NHS Foundation Trust1
Safaa AA Khaled1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders17
Hypertension, Portal2
Thrombosis2
Anemia, Aplastic1
Hypertension, Pulmonary1
Leukemia1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Neoplasms1
Thrombocytosis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.